Munich - Delayed Quote EUR
Couchbase, Inc. (1V3.MU)
14.90
0.00
(0.00%)
At close: April 30 at 8:00:48 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 16 | 16 |
| Avg. Estimate | 55.59M | 56.46M | 230M | 260.67M |
| Low Estimate | 55.1M | 55.6M | 228.05M | 253.07M |
| High Estimate | 56.86M | 57.32M | 232.2M | 267.8M |
| Year Ago Sales | 51.33M | 51.59M | 209.47M | 230M |
| Sales Growth (year/est) | 8.30% | 9.44% | 9.80% | 13.33% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1V3.MU | -- | -- | -- | -- |
| S&P 500 | 9.70% | 3.97% | 8.29% | 13.85% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 4/23/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/16/2025 |
| Initiated | Rosenblatt: Buy | 4/9/2025 |
| Maintains | Goldman Sachs: Sell to Sell | 2/27/2025 |
| Maintains | UBS: Neutral to Neutral | 2/26/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 2/26/2025 |